Sandbox spinalcord
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Lower gastrointestinal bleeding, commonly abbreviated LGIB, refers to any form of bleeding in the lower gastrointestinal tract.
Causes
- Coagulopathy - specifically a bleeding diathesis
- Colitis
- Hemorrhoids
- Angiodysplasia
- Neoplasm - cancer
- Diverticular disease - diverticulosis, diverticulitis
Diagnosis
The following suggest an LGIB:
- Melena and a negative oesophagogastroduodenoscopy
- Hematochezia
- Fecal occult blood
The following may suggest an LGIB:
Related Chapter
Blood in stools | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abdominal pain | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fever | Rectal pain | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
H/O of constipation | H/O of constipation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Weightloss | Diverticulosis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hemodynamic status | Diverticulitis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stable | Unstable | Polyps | Colon cancer | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Weight Loss | Anal fissure External Hemmrhoids | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rectal cancer Colon cancer | Angiodysplasia Polyps | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Management
Hepatic adenoma
Management of hepatic adenoma depends upon:
- Symptoms
- Size
- Number
- Location
- Certainty of the diagnosis
Asymptomatic woman on OCPs with a small adenoma
The European Association for Study of the Liver recommends
- Discontinuation of contraceptive medication
- Close observation of the lesion with repeated imaging and alpha fetoprotein.
- Contrast-enhanced magnetic resonance imaging at a six month interval to determine if there is regression of a large adenoma to less than 5 cm.
- Patients with hepatic adenomas that do not resolve or that enlarge after six months of observation should undergo treatment.
Symptomatic patients and those with large adenomas
- Surgical resection is recommended for all symptomatic patients with hepatic adenoma and those with large lesions (>5 cm).
- Surgical options include :
- Enucleation
- Resection
- Liver transplantation
- Nonsurgical interventions include
- Transarterial embolization
- Radiofrequency ablation
Hepatic Hemangioma
- Asymptomatic patients
- Patients with lesions <1.5 cm, are reassured and observed.
- Follow-up imaging in patients with hemangiomas ≤5 cm in size is usually not recommended.
- Patients with rapid growth of a hemangioma or with lesions >5 cm it is recommended to repeat imaging in 6 to 12 months.
- It is recommended not perform additional imaging if there is no change in the size of the lesion.
- Symptomatic patients
- Patients who have pain or symptoms suggestive of extrinsic compression of adjacent structures should be considered for surgical options.
- Surgical options include
- Liver resection
- Enucleation
- Hepatic artery ligation
- Liver transplantation
- Non-surgical techniques include
- Hepatic artery embolization
- Radiotherapy
- Interferon alfa-2a
Focal nodular hyperplasia
- Due to their benign nature of focal nodular hyperplasia, there is
- Follow-up studies at three and six months will often be sufficient to confirm the stability of the lesion and its benign nature, after which no long-term follow-up is required routinely.
- Surgery should be reserved for symptomatic FNH lesion.
Parasitic Infection | Mode of infection | Epidemiology | Clinical manifestations | Diagnosis | Treatment | ||
---|---|---|---|---|---|---|---|
Disease | Parasite | Laboratory findings | Imaging | ||||
Ascariasis | |||||||
Necatoriasis | |||||||
Giardiaisis | |||||||
Fasciolosis | |||||||
Schistosomiasis | |||||||
Strongyloidiasis | |||||||
Amoebiais | |||||||
Taeniasis | |||||||
Trichuriasis | Trichuris trichiura |
|
|
| |||
Hymenolepiasis | Hymenolepis nana | Ingestion of infected eggs | Most common in temperate zones[3]
|
|
|
|
- ↑ Rossignol JF, Maisonneuve H (1984). "Benzimidazoles in the treatment of trichuriasis: a review". Ann Trop Med Parasitol. 78 (2): 135–44. PMID 6378109.
- ↑ Steinmann P, Utzinger J, Du ZW, Jiang JY, Chen JX, Hattendorf J; et al. (2011). "Efficacy of single-dose and triple-dose albendazole and mebendazole against soil-transmitted helminths and Taenia spp.: a randomized controlled trial". PLoS One. 6 (9): e25003. doi:10.1371/journal.pone.0025003. PMC 3181256. PMID 21980373.
- ↑ Utzinger J, Botero-Kleiven S, Castelli F, Chiodini PL, Edwards H, Köhler N; et al. (2010). "Microscopic diagnosis of sodium acetate-acetic acid-formalin-fixed stool samples for helminths and intestinal protozoa: a comparison among European reference laboratories". Clin Microbiol Infect. 16 (3): 267–73. doi:10.1111/j.1469-0691.2009.02782.x. PMID 19456836.
- ↑ Muehlenbachs A, Bhatnagar J, Agudelo CA, Hidron A, Eberhard ML, Mathison BA; et al. (2015). "Malignant Transformation of Hymenolepis nana in a Human Host". N Engl J Med. 373 (19): 1845–52. doi:10.1056/NEJMoa1505892. PMID 26535513.
- ↑ Steinmann P, Cringoli G, Bruschi F, Matthys B, Lohourignon LK, Castagna B; et al. (2012). "FLOTAC for the diagnosis of Hymenolepis spp. infection: proof-of-concept and comparing diagnostic accuracy with other methods". Parasitol Res. 111 (2): 749–54. doi:10.1007/s00436-012-2895-9. PMID 22461006.
- ↑ Ohnishi K, Sakamoto N, Kobayashi K, Iwabuchi S, Nakamura-Uchiyama F (2013). "Therapeutic effect of praziquantel against Taeniasis asiatica". Int J Infect Dis. 17 (8): e656–7. doi:10.1016/j.ijid.2013.02.028. PMID 23618773.
- ↑ Pawłowski ZS (1990). "Efficacy of low doses of praziquantel in taeniasis". Acta Trop. 48 (2): 83–8. PMID 1980572.